ALFA Filings
Every announcement, straight from the exchange
Every Sakar Healthcare results update announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Sakar Healthcare reported Q2 FY27 revenue of ₹87.42 Cr and PAT of ₹11.31 Cr, up 149% YoY. EBITDA rose 114% to ₹24.35 Cr on strong oncology approvals and commercial supply commencement.
Sakar Healthcare announced Q1FY27 results, reporting 38% YoY revenue growth. Strong operating performance was driven by oncology product contracts and global dossier approvals.
Sakar Healthcare reported FY26 revenue of ₹251.74 Crore, a 42% YoY increase. EBITDA rose 39% to ₹68.89 Crore, driven by strong oncology product performance.